Media & Awards

   Watch 9 News segment

"We want to take out as much prostate as we can to cure the patient, but leave enough nerves behind that they have good function afterwards," Epworth urologist Professor Nathan Lawrentschuk said.

"In real time, we can use digital images now in a matter of minutes to discover whether we've taken enough of the prostate out," Lawrentschuk said.

   Watch video segment

"When we created the center, just over five years ago, our vision was number one, to bring the best treatments for men with prostate cancer. Number two, to raise awareness of prostate cancer in the community. And number three, to be involved in international high-end quality research.

We're extremely lucky to have access to treatments such as the NanoKnife because of donations and the foundation and having a research center around it. And we are best placed, I believe, to do these sorts of treatments, not because we can just do them, but because we study, learn, and get better at them."

   Read USANZ news article

Professor Nathan Lawrentschuk won the Best Poster Presentation in the Penile Cancer section. Nathan's research examines how artificial intelligence will accurately allow men and health workers to take photos of penile lesions to help determine if they could be cancerous, from home if required, aiding in early detection of this disease.

   Listen to radio segment

“Kidney stones do cause a lot of pain”, according to Associate Professor Nathan Lawrentschuk, Director of the E.J. Whitten Prostate Cancer Research Centre at Epworth Healthcare.

“The pain comes about when the stones, which form in the kidney, are trying to find their way down a tube called the urethra which connects the kidney to the bladder. On the way down the stones can unfortunately get stuck and of course that sends the pain receptors a bit out of kilter.”

   Listen to radio segment

Associate Professor Nathan Lawrentschuk, director of the EJ Whitten Prostate Cancer Research Centre, is excited about the medical advancements.

“It doesn’t mean that there’ll be no cancer in the rest of the prostate but the idea is that those cancers that are not treated will be small and low-grade, and not grow into trouble for the man but will treat the significant cancer – the one that may in fact escape and cause troubles for that patient,” he told Ross and John.